Cargando…

The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates

BACKGROUND: As both life expectancy and cancer survival improve, the incidence of multiple primary cancer has augmented and is expected to further increase. This study describes for the first time the epidemiology of multiple invasive tumours in Belgium. METHODS: This nationwide study, based on all...

Descripción completa

Detalles Bibliográficos
Autores principales: Macq, Gilles, Silversmit, Geert, Verdoodt, Freija, Van Eycken, Liesbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108509/
https://www.ncbi.nlm.nih.gov/pubmed/37069565
http://dx.doi.org/10.1186/s12885-023-10777-7
_version_ 1785026863086698496
author Macq, Gilles
Silversmit, Geert
Verdoodt, Freija
Van Eycken, Liesbet
author_facet Macq, Gilles
Silversmit, Geert
Verdoodt, Freija
Van Eycken, Liesbet
author_sort Macq, Gilles
collection PubMed
description BACKGROUND: As both life expectancy and cancer survival improve, the incidence of multiple primary cancer has augmented and is expected to further increase. This study describes for the first time the epidemiology of multiple invasive tumours in Belgium. METHODS: This nationwide study, based on all cancers diagnosed between 2004 and 2017 in Belgium, describes the proportion of multiple primary cancer, its evolution over time, the impact of inclusion or exclusion of multiple primary cancer on relative survival estimates, the risk of developing a second primary cancer, and the difference in stage between first and second primary cancer for the same patient. RESULTS: The proportion of multiple primary cancer increases with age, varies across cancer sites (from 4% for testis cancer to 22.8% for oesophageal cancer), is higher in men than in women, and has linearly increased over time. The inclusion of multiple primary cancer resulted in smaller 5-year relative survival and this impact is more pronounced in cancer sites with high relative survival. Patients with a first primary cancer have an increased risk to develop a new primary cancer compared to the population without a previous cancer history (1.27 and 1.59 times higher in men and women, respectively) and this risk depends on cancer site. Second primary cancers are associated with more advanced stages and more unknown stages than the corresponding first cancer diagnosis. CONCLUSIONS: This study describes multiple primary cancer according to several measures (proportion, standardised incidence ratio for an second primary cancer, impact of multiple primary cancer on relative survival and differences according to stage) for the first time in Belgium. The results are based on data of a population-based cancer registry with a relatively recent onset (2004). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10777-7.
format Online
Article
Text
id pubmed-10108509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101085092023-04-18 The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates Macq, Gilles Silversmit, Geert Verdoodt, Freija Van Eycken, Liesbet BMC Cancer Research BACKGROUND: As both life expectancy and cancer survival improve, the incidence of multiple primary cancer has augmented and is expected to further increase. This study describes for the first time the epidemiology of multiple invasive tumours in Belgium. METHODS: This nationwide study, based on all cancers diagnosed between 2004 and 2017 in Belgium, describes the proportion of multiple primary cancer, its evolution over time, the impact of inclusion or exclusion of multiple primary cancer on relative survival estimates, the risk of developing a second primary cancer, and the difference in stage between first and second primary cancer for the same patient. RESULTS: The proportion of multiple primary cancer increases with age, varies across cancer sites (from 4% for testis cancer to 22.8% for oesophageal cancer), is higher in men than in women, and has linearly increased over time. The inclusion of multiple primary cancer resulted in smaller 5-year relative survival and this impact is more pronounced in cancer sites with high relative survival. Patients with a first primary cancer have an increased risk to develop a new primary cancer compared to the population without a previous cancer history (1.27 and 1.59 times higher in men and women, respectively) and this risk depends on cancer site. Second primary cancers are associated with more advanced stages and more unknown stages than the corresponding first cancer diagnosis. CONCLUSIONS: This study describes multiple primary cancer according to several measures (proportion, standardised incidence ratio for an second primary cancer, impact of multiple primary cancer on relative survival and differences according to stage) for the first time in Belgium. The results are based on data of a population-based cancer registry with a relatively recent onset (2004). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10777-7. BioMed Central 2023-04-17 /pmc/articles/PMC10108509/ /pubmed/37069565 http://dx.doi.org/10.1186/s12885-023-10777-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Macq, Gilles
Silversmit, Geert
Verdoodt, Freija
Van Eycken, Liesbet
The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title_full The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title_fullStr The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title_full_unstemmed The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title_short The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates
title_sort epidemiology of multiple primary cancers in belgium (2004–2017): incidence, proportion, risk, stage and impact on relative survival estimates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108509/
https://www.ncbi.nlm.nih.gov/pubmed/37069565
http://dx.doi.org/10.1186/s12885-023-10777-7
work_keys_str_mv AT macqgilles theepidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT silversmitgeert theepidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT verdoodtfreija theepidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT vaneyckenliesbet theepidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT macqgilles epidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT silversmitgeert epidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT verdoodtfreija epidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates
AT vaneyckenliesbet epidemiologyofmultipleprimarycancersinbelgium20042017incidenceproportionriskstageandimpactonrelativesurvivalestimates